openPR Logo
Press release

Global Xerostomia Therapeutics Market Analysis by Type, Prescription Based, Geography and Key Industry Competitors Colgate-Palmolive, Church & Dwight Co., Inc., GSK, Hikma Pharmaceuticals, Lupin Pharmaceuticals, Pfizer, SUN PHARMA

03-05-2019 04:00 PM CET | Health & Medicine

Press release from: Data Bridge Market Research

Global Xerostomia Therapeutics Market

Global Xerostomia Therapeutics Market

Acacia Pharma Limited, Colgate-Palmolive, Church & Dwight Co., Inc., GSK, Hikma Pharmaceuticals, Lupin Pharmaceuticals, PENDOPHARM, Pfizer, SUN PHARMA, Synedgen, Inc these are the main players who are dominating the Xerostomia Therapeutics Market and are affecting the sales, import, export and revenue at a global level.

The global Xerostomia Therapeutics Market is growing day by day this report contains all the data needed to as good as the dominating players and become a BRAND. The report contains information like market definition, classifications, applications and market trends and also the global Xerostomia Therapeutics Market CAGR levels. The report informs the user about all the drivers and restrains which are derived from SWOT analysis and the unique method of Porter's Five Forces Analysis which informs about the threat of new entrants, threat of substitutes, bargaining power of customers, bargaining power of suppliers, Industry rivalry to the organizations in the Xerostomia Therapeutics industry.

Download Free PDF Sample Copy of Report @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-xerostomia-therapeutics-market

Global Xerostomia Therapeutics Market is expected to rise from its initial estimated value of USD 648.94 billion in 2018 to an estimated value of USD 874.55 billion by 2026 registering a CAGR of 3.8% in the forecast period of 2019-2026. This rise in the market can be attributed to the rising geriatric population over the world and prevalence of demand of arthroscopy in these populations.

Global Xerostomia Therapeutics Market, By Type (Salivary Stimulants, Salivary Substitutes, Dentifrices), Prescription based (OTC, Prescribed), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa)- Industry Trends and Forecast to 2026

Xerostomia is a disease leading to oral dryness and are not easily diagnosed. Dryness of mouth is associated with the altered salivary gland functionality and other etiologies causing oral issues. Xerostomia caused due to the absence of saliva flow, and this is due to shrinkage of salivary gland. The xerostomia therapeutics helps to treat these symptoms associated with the dry mouth. The dry mouth symptoms impacts the life style quality of the patient and causes difficulty in the swallowing, chewing and speaking which can lead to the thick oral mucus, sleep disturbance and bad breathing.

Market Drivers:

• Rising geriatric population has increased the demand for these therapeutics as the elderly population have more symptoms of dry mouth

• Increase in use of prescription medications

Key Developments in the Market:

In October 2018, Synedgen Incand the subsidiary Prisyna, announced the launch of Moisyn for the treatment of xerostomia dry mouth.

May 2018, Synedgen Inc. and the subsidiary Prisyna , received 510(k) clearance from the US Food and Drug Administration (FDA) to market its family of Moisyn products designed to treat xerostomia. The clearance of the drug from FDA will help the company to provide the Moisyn products to the patients for the treatment and can alleviate the dry mouth symptoms.

Table Of Content:

Part 01: Executive Summary
Part 02: Scope Of The Report
Part 03: Global Xerostomia Therapeutics Market Landscape
Part 04: Global Xerostomia Therapeutics Market Sizing
Part 05: Global Xerostomia Therapeutics Market Segmentation By Product
Part 06: Five Forces Analysis
Part 07: Customer Landscape
Part 08: Geographic Landscape
Part 09: Decision Framework
Part 10: Drivers And Challenges
Part 11: Market Trends
Part 12: Vendor Landscape
Part 13: Vendor Analysis

And More…..Get Detailed TOC @ https://databridgemarketresearch.com/toc/?dbmr=global-xerostomia-therapeutics-market

Competitive Analysis: Global Xerostomia Therapeutics Market

The global xerostomia therapeutics market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of xerostomia therapeutics market for global, Europe, North America, Asia Pacific, South America and Middle East & Africa.

Reasons to Purchase this Report:

• Current and future of global xerostomia therapeutics market outlook in the developed and emerging markets

• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period

• Regions/Countries that are expected to witness the fastest growth rates during the forecast period

• The latest developments, market shares, and strategies that are employed by the major market players

Segmentation: Global Xerostomia Therapeutics Market

By Type

• Salivary Stimulants

• Salivary Substitutes

• Dentifrices

By Prescription Based

• OTC

• Prescribed

By Geography

• North America

• South America

• Europe

• Asia-Pacific

• Middle East and Africa

Order a Copy of This Research Report @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-xerostomia-therapeutics-market

About Us:

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune. We ponder into the heterogeneous markets in accord with our clients needs and scoop out the best possible solutions and detailed information about the market trends. Data Bridge delve into the markets across Asia, North America, South America, Africa to name few.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact:

Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Xerostomia Therapeutics Market Analysis by Type, Prescription Based, Geography and Key Industry Competitors Colgate-Palmolive, Church & Dwight Co., Inc., GSK, Hikma Pharmaceuticals, Lupin Pharmaceuticals, Pfizer, SUN PHARMA here

News-ID: 1633917 • Views:

More Releases from Data Bridge Market Research

Water Treatment System Market: Sustaining the Future of Clean Water
Water Treatment System Market: Sustaining the Future of Clean Water
Introduction Understanding Water Treatment Systems Water treatment systems are designed to purify and disinfect water for various uses-drinking, industrial processes, irrigation, and wastewater reuse. These systems eliminate contaminants such as bacteria, viruses, heavy metals, chemicals, and particulates, making water safe and sustainable for consumption and use. Importance in Global Sustainability Clean water is essential to life and industrial progress. With growing water demand and pollution, water treatment systems are now critical infrastructure across the
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032. With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032. With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032. With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal

All 5 Releases


More Releases for Xerostomia

Xerostomia Therapeutics Market - Expansion & Opportunities Ahead 2025-2035
23 April 2025, Metatech Insights - The Global Research Report Provides a Detailed Analysis of Xerostomia Therapeutics Market, Based on Competitive Intensity and How the Competition Will Take Shape in Coming Years. Latest released the research study on Global Xerostomia Therapeutics Market, offers a detailed overview of the factors influencing the global business scope. Xerostomia Therapeutics Market research report shows the latest market insights, current situation analysis with upcoming trends and
Top Factor Driving Xerostomia Therapeutics Market Growth in 2025: Chemotherapy's …
Get 20% off on all our 2025 Global Market Reports with code FY25SAVE - Offer valid till March 31st!
Top Factor Driving Xerostomia Therapeutics Market Growth in 2025: Chemotherapy's …
Get 20% off on all our 2025 Global Market Reports with code FY25SAVE - Offer valid till March 31st!
Xerostomia (Dry Mouth) Market: An In-Depth Analysis
𝐓𝐡𝐞 𝐠𝐥𝐨𝐛𝐚𝐥 𝐗𝐞𝐫𝐨𝐬𝐭𝐨𝐦𝐢𝐚 (𝐝𝐫𝐲 𝐦𝐨𝐮𝐭𝐡) 𝐦𝐚𝐫𝐤𝐞𝐭 𝐰𝐚𝐬 𝐯𝐚𝐥𝐮𝐞𝐝 𝐚𝐭 𝐚𝐩𝐩𝐫𝐨𝐱𝐢𝐦𝐚𝐭𝐞𝐥𝐲 𝐔𝐒𝐃 𝟐.𝟏 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝟐𝟎𝟐𝟑 𝐚𝐧𝐝 𝐢𝐬 𝐩𝐫𝐨𝐣𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐫𝐞𝐚𝐜𝐡 𝐚𝐫𝐨𝐮𝐧𝐝 𝐔𝐒𝐃 𝟑.𝟏 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟐, 𝐫𝐞𝐟𝐥𝐞𝐜𝐭𝐢𝐧𝐠 𝐚 𝐜𝐨𝐦𝐩𝐨𝐮𝐧𝐝 𝐚𝐧𝐧𝐮𝐚𝐥 𝐠𝐫𝐨𝐰𝐭𝐡 𝐫𝐚𝐭𝐞 (𝐂𝐀𝐆𝐑) 𝐨𝐟 𝟒.𝟏%.⁣ ⁣ 𝐗𝐞𝐫𝐨𝐬𝐭𝐨𝐦𝐢𝐚 (𝐃𝐫𝐲 𝐌𝐨𝐮𝐭𝐡) 𝐌𝐚𝐫𝐤𝐞𝐭 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰 The xerostomia (dry mouth) market is growing due to the increasing prevalence of conditions such as diabetes, Sjögren's syndrome, and cancer treatments like radiation therapy, which contribute to dry mouth symptoms. The
Xerostomia Therapeutics Market Analysis, Size, Share & Trends | 2031
In recent years, the global Xerostomia Therapeutics Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Xerostomia Therapeutics Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot of business matrices including Porters Five
Xerostomia Treatment Market Size, Share, Report and Forecast 2032
Xerostomia Treatment Market Outlook The xerostomia treatment market is anticipated to grow at a CAGR of 3.5 % during the forecast period of 2024-2032. Xerostomia Treatment: Introduction Xerostomia, commonly known as dry mouth, is a condition characterised by a significant decrease in saliva production. This can lead to discomfort, difficulties in speaking, chewing, and swallowing, as well as an increased risk of dental decay and oral infections. Xerostomia treatment aims to alleviate these